Tuesday☕️

Tuesday☕️

Trending:

  • Tesla Self Driving Capabilities
  • ADHD Medication Side Effects

Markets:

  • Yesterday’s U.S. stock market:
TradingView
  • Yesterday’s commodity market:
TradingView @7:22 PM EST
  • Yesterday’s crypto market:
TradingView @9:22 PM EST

Tesla Self Driving Capabilities:

  • The new FSD v12 update from Tesla marks a significant shift in how the vehicle's self-driving system operates. Previously, the vehicle controls for Tesla's self-driving features were hardcoded by engineers. This means that specific instructions and rules for driving behaviors were programmed into the system by developers.
  • The car would respond to various driving scenarios based on these pre-set rules and algorithms. With the FSD v12 update, Tesla is transitioning to having these vehicle controls managed by neural networks. Neural networks are a form of artificial intelligence that mimic the human brain's way of processing information.
  • They are capable of learning and making decisions based on data they receive. In the context of Tesla's self-driving cars, this means the system can continuously learn and adapt from vast amounts of data gathered from the driving environment. Instead of relying on fixed programming for making driving decisions, the car will now use advanced AI algorithms that can process real-time data, learn from new situations, and make decisions more like a human driver would.
  • This allows for a more dynamic and adaptable self-driving system, which can potentially handle a wider range of driving scenarios more effectively than humans overtime. However, it's important to note that while this technology represents a significant advancement, the responsibility for driving still legally rests with the human driver, as the technology has not yet reached a stage where it can fully replace human judgment and control.

ADHD Medication Side Effects:

  • In a significant study published in the JAMA Psychiatry journal, Swedish researchers have uncovered a correlation between the use of ADHD medications, such as Ritalin and Adderall, and an elevated risk of developing heart disease. The study methodically compared the incidence of heart conditions among individuals on these medications to those not using them.
  • The findings indicated a clear trend: irrespective of age or initial health conditions, the longer the duration of ADHD medication use, the higher the likelihood of developing heart-related issues such as high blood pressure. While the study acknowledges the considerable benefits that ADHD medications offer, it also brings to light the importance of further investigation into their long-term effects.
  • This aspect of the research underscores a critical need in the medical community to balance the effective treatment of ADHD with the potential cardiovascular risks that may arise from prolonged medication use. In light of these findings, the researchers suggest that it’s essential for healthcare providers and patients to be proactive in monitoring heart health, particularly in those undergoing long-term treatment with ADHD medications.

Statistic:

Top 50 largest pharmaceutical companies by market capitalization:

  1. 🇺🇸 Eli Lilly: $561.54B
  2. 🇩🇰 Novo Nordisk: $467.58B
  3. 🇺🇸 Johnson & Johnson: $364.17B
  4. 🇺🇸 Merck: $257.02B
  5. 🇺🇸 AbbVie: $245.56B
  6. 🇨🇭 Roche: $218.32B
  7. 🇨🇭 Novartis: $200.90B
  8. 🇬🇧 AstraZeneca: $197.72B
  9. 🇺🇸 Pfizer: $170.18B
  10. 🇺🇸 Amgen: $141.43B
  11. 🇫🇷 Sanofi: $119.49B
  12. 🇺🇸 Bristol-Myers Squibb: $99.74B
  13. 🇺🇸 Gilead Sciences: $93.35B
  14. 🇺🇸 Vertex Pharmaceuticals: $90.23B
  15. 🇺🇸 CVS Health: $88.46B
  16. 🇺🇸 Regeneron Pharmaceuticals: $86.94B
  17. 🇦🇺 CSL: $82.37B
  18. 🇺🇸 Zoetis: $82.08B
  19. 🇩🇪 Merck KGaA: $76.18B
  20. 🇬🇧 GlaxoSmithKline: $72.95B
  21. 🇯🇵 Chugai Pharmaceutical: $54.78B
  22. 🇯🇵 Daiichi Sankyo: $50.87B
  23. 🇯🇵 Takeda Pharmaceutical: $44.15B
  24. 🇨🇳 Jiangsu Hengrui Medicine: $41.87B
  25. 🇺🇸 Seagen: $40.45B
  26. 🇨🇳 WuXi AppTec: $35.23B
  27. 🇮🇳 Sun Pharmaceutical: $34.38B
  28. 🇩🇪 Bayer: $34.09B
  29. 🇺🇸 Biogen: $33.15B
  30. 🇺🇸 Moderna: $29.63B
  31. 🇳🇱 Argenx: $29.28B
  32. 🇨🇭 Lonza: $29.10B
  33. 🇮🇪 Horizon Therapeutics: $26.63B
  34. 🇺🇸 West Pharmaceutical: $26.18B
  35. 🇨🇳 WuXi Biologics: $25.14B
  36. 🇩🇪 BioNTech: $23.22B
  37. 🇮🇪 ICON plc: $22.17B
  38. 🇯🇵 Astellas Pharma: $21.78B
  39. 🇯🇵 Otsuka Holdings: $20.41B
  40. 🇩🇰 Genmab: $20.05B
  41. 🇺🇸 Alnylam Pharmaceuticals: $19.97B
  42. 🇨🇳 BeiGene: $19.69B
  43. 🇺🇸 Baxter: $18.47B
  44. 🇺🇸 LabCorp: $18.06B
  45. 🇰🇷 Celltrion: $17.56B
  46. 🇺🇸 Walgreens Boots Alliance: $17.37B
  47. 🇺🇸 BioMarin Pharmaceutical: $16.68B
  48. 🇬🇧 Royalty Pharma: $16.27B
  49. 🇯🇵 Eisai: $14.71B
  50. 🇧🇪 UCB: $14.50B

Article Links:

Open Source Software
The Essence of Open Source Software (OSS) Open Source Software (OSS) embodies a collaborative, transparent, and freely accessible approach to software development. It thrives on community involvement, where individuals and organizations across the globe contribute to and utilize shared software res…
Quantum Computing
Quantum computing is a new technology designed to process information faster and more efficiently than traditional computing. Unlike traditional computing, which uses simple binary units of data (bits) to perform calculations, quantum computing uses quantum bits (qubits), which can exist in multiple…

Thanks for reading!

TIME IS MONEY: Your Free Daily Scoop of Markets📈, Business💼, Tech📲🚀, and Global 🌎 News.

The news you need, the time you want.

TIME IS MONEY
TIME IS MONEY: A Free Daily Email Newsletter of Markets📈, Business💼, Tech📲🚀, and Global 🌎 News.

Support/Suggestions Emails:

timeismoney@timeismon.news